Central Pharmaceutical JSC No2 (HSTC:DP2) Debt-to-Asset : 0.00 (As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HSTC:DP2 Central Pharmaceutical JSC No2 HSTC:DP2
23 GF Score
Price ₫4,900.00
View Full Analysis

What is Central Pharmaceutical JSC No2 Debt-to-Asset?

Central Pharmaceutical JSC No2 HSTC:DP2 23 Debt-to-Asset is 0.00 as of . 20. GuruFocus rates HSTC:DP2 with a GF Score™ of 23/100.

Central Pharmaceutical JSC No2's Short-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was ₫0.00 Mil. Central Pharmaceutical JSC No2's Long-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was ₫0.00 Mil. Central Pharmaceutical JSC No2's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in . 20 was ₫0.00 Mil.

Central Pharmaceutical JSC No2  (HSTC:DP2) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Central Pharmaceutical JSC No2 Debt-to-Asset Related Terms

Central Pharmaceutical JSC No2 Debt-to-Asset Historical Data

* Premium members only.

The historical data trend for Central Pharmaceutical JSC No2's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Central Pharmaceutical JSC No2 Debt-to-Asset Chart

Central Pharmaceutical JSC No2 Annual Data
Trend
Debt-to-Asset

Central Pharmaceutical JSC No2 Semi-Annual Data
Debt-to-Asset

HSTC:DP2 vs : Debt-to-Asset Comparison

For the Pharmaceutical Retailers subindustry, Central Pharmaceutical JSC No2's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Central Pharmaceutical JSC No2 Debt-to-Asset vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Central Pharmaceutical JSC No2's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Central Pharmaceutical JSC No2's Debt-to-Asset falls into.


HSTC:DP2
23GF Score
Central Pharmaceutical JSC No2 HSTC:DP2
Debt-to-Asset is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Central Pharmaceutical JSC No2 Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Central Pharmaceutical JSC No2's Debt-to-Asset for the fiscal year that ended in . 20 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=( + ) /
=N/A

Central Pharmaceutical JSC No2's Debt-to-Asset for the quarter that ended in . 20 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=( + ) /
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Debt-to-Asset →
What does a Debt-to-Asset of 0.00 mean?
Central Pharmaceutical JSC No2 (HSTC:DP2) has a Debt-to-Asset of 0.00 as of . 20. Debt-to-asset ratio represents the ratio of total debt to total assets. View historical data on Central Pharmaceutical JSC No2 and its competitors.
Is Central Pharmaceutical JSC No2's Debt-to-Asset too high?
Central Pharmaceutical JSC No2's current Debt-to-Asset is 0.00. Overall, Central Pharmaceutical JSC No2 has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Central Pharmaceutical JSC No2's Debt-to-Asset compare to ?
Central Pharmaceutical JSC No2's Debt-to-Asset of 0.00 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Asset for a Healthcare Providers & Services company?
A good Debt-to-Asset depends on the Healthcare Providers & Services industry context. However, Debt-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Asset mean?
A high Debt-to-Asset can signal that a stock is expensive relative to its fundamentals. Debt-to-asset ratio represents the ratio of total debt to total assets. View historical data on Central Pharmaceutical JSC No2 and its competitors. Central Pharmaceutical JSC No2's current Debt-to-Asset is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Central Pharmaceutical JSC No2 stock overvalued right now?
Central Pharmaceutical JSC No2 (HSTC:DP2) has a current Debt-to-Asset of 0.00. The current Debt-to-Asset is 0.00. Central Pharmaceutical JSC No2's overall GF Score™ is 23/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Asset calculated?
Debt-to-Asset is calculated from a company's financial statements. For Central Pharmaceutical JSC No2 (HSTC:DP2), the current Debt-to-Asset is 0.00 as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Central Pharmaceutical JSC No2 Business Description

Comparable Companies
Address No. 9 Tran Thanh Tong, Bach Dang Ward, Hai Ba Trung District, Hanoi, VNM
Central Pharmaceutical JSC No2 is engaged in the Trading of medicinal materials, pharmaceutical materials, chemicals, essential oils, modern medicines, traditional medicine drugs, cosmetics, and nutritious foods. Some of its products include Gentamycin injection solution 80; Genatreson Skin Cream; Ferimax Hard Capsules and others.
23GF Score

Get the complete analysis for HSTC:DP2

Debt-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₫4,900.00
Price